Add Yahoo as a preferred source to see more of our stories on Google. TikTok @fizy_vizy_vlogs/TikTok @ehsan1630/TikTok (TikTok @fizy_vizy_vlogs/TikTok @ehsan1630/TikTok) In the days leading up to New ...

British singer/songwriter Chris Rea, who had a hit in the '70s with “Fool (If You Think it’s Over),” has passed away at the age of 74. His death was confirmed in a statement posted on his Facebook ...

Chris Rea, the rock singer who was best known for hits including “Driving Home For Christmas” and “Fool (If You Think It’s Over),” has died following a short illness. He was 74. “It is with immense ...

I have a good friend who received a Christmas card with a cartoon of a very smug cat on the front that, when opened, began playing a chorus of cats signing “A Very Meowy Christmas.” Amusing at first, ...

Most April Fool’s Day pranks end with someone being tricked, but BMW New Zealand flipped that script in 2015. Instead of fooling people, they rewarded one. A mysterious ad in the paper promised a new ...

Calling all Only Fools and Horses fans as a new docuseries with never-before-seen footage is about to be released to mark the show's 45th anniversary. Titled Only Fools and Horses: The Lost Archive, ...

A. It’s when many companies’ earnings reports are released. Public companies (those with publicly traded stock) must issue three quarterly “10-Q” reports and an annual “10-K” report (for their fourth ...

Venture Global delivered mixed results and lowered full-year profit expectations. Customers are suing Venture Global over past undelivered cargoes, with a revived legal challenge during the month. But ...

The FDA has granted accelerated approval to Otsuka’s sibeprenlimab (Voyxact) for proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. The monoclonal ...

With Thanksgiving approaching, the film "Pieces of April" is widely available on streaming platforms and makes for a timely, emotionally rich holiday watch. Why "Pieces of April" Is a Great ...

Analysts at Guggenheim Partners expect Voyxact to see “broad commercial uptake” given its relatively broad label compared with previous accelerated approvals for IgA nephropathy. The FDA has granted ...